Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Next Science - FY23 Annual Result Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science reports FY23 Result (ASX:NXS)

-- Revenue of US$22.2m, up 89% year-on-year (yoy) with 2H FY23 revenue of US$12.1m in line with 2H FY23 guidance of US$12m-14m provided in October 2023 -- Product Sales of US$22.1m, up 90% yoy refl...read more

Next Science - Appendix 4E / FY23 Financial Statements (ASX:NXS)

To view the appendix, download the attached PDF.

Next Science - Appendix 4C & Quarterly Activity Report - 31 December 2023 (ASX:NXS)

-- FY23 Revenue of US$22.2m, up 89.4% on pcp2 with 2H FY23 revenue of US$12.1m in line with 2H FY23 guidance of US$12m-14m provided in October 2023. -- 4Q FY23 Product Sales of US$7.1m, up 123.5% o...read more

Next Science - XPERIENCE study findings published (ASX:NXS)

Publication of knee study showing potential anti-inflammatory benefit for XPERIENCE Next Science Limited (ASX:NXS) (“Next Science” or “the Company”) today announces the pu...read more

Next Science - Response to ASX Aware Letter (ASX:NXS)

Dear Ms Banh ASX QUERY I refer to your letter dated 3 November 2023 regarding ASX's queries in respect of Next Science Limited (“Next Science” or “Company”), and sp...read more

Next Science - XPERIENCE study findings released (ASX:NXS)

Study finds Infection Prevention Benefit in Periprosthetic Joint Surgery for XPERIENCE™ ADVANCED SURGICAL IRRIGATION Highlights: Dr. Robert Harris MD has released the finding...read more

Next Science - Investor Presentation - Q3 2023 (ASX:NXS)

To view the Investor Presentation, download the attached PDF.

Next Science - Quarterly Activity Report - 30 September 2023 (ASX:NXS)

Highlights: Discipline and diligence around quality of revenue realised significant increase in Gross Margin. Quarterly Gross Profit increased from $2.4m to $3.8m yoy. 3QFY2...read more

Next Science - Appendix 4C - 30 September 2023 (ASX:NXS)

To view the Appendix 4C, download the attached PDF.

Next Science - Successful completion of Share Purchase Plan & US Offer (ASX:NXS)

Sydney, Australia Friday, 22 September 2023, Next Science Limited (ASX:NXS) (Next Science or the Company), a medical technology company focused on commercialising its proprietary XBIO™ suite o...read more

Next Science - Half Year Report & Appendix 4D (ASX:NXS)

To view the Half Year Report & Appendix 4D, download the attached PDF.

Next Science - Half Year Results & Capital Raise Update (ASX:NXS)

Highlights: - 1HFY23 Product Sales increased 92%yoy to US$10.0m - 1HFY23 Direct Product Sales increased 226% yoy - 1HFY23 Gross Margin of 68% v 81% pcp reflects changing product mix - 1HFY23 U...read more

Next Science - Half Year Results & Capital Raise Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Trading Halt (ASX:NXS)

The securities of Next Science Limited (‘NXS’) will be placed in trading halt at the request of NXS, pending it releasing an announcement. Unless ASX decides otherwise, the securities wi...read more

Viewing: 1 - 15 of 200 Previous | Next